Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Go back to Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine| (NASDAQ: BNTX) | Delayed: 98.34 +2.28 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $96.06 | 52 Week High | $ | |||
| Open | $97.25 | 52 Week Low | $ | |||
| Day High | $98.49 | P/E | N/A | |||
| Day Low | $96.61 | EPS | $ | |||
| Volume | 216,526 | |||||
